Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug
Coronary Heart Disease, How To Use The Right Medication?
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
Cancer Institute Hospital of JFCR
Breast Cancer: a Brighter Future For Patients As New Cutting-Edge Drugs Continue To Emerge!
Innovative Therapy Zolbetuximab In Combination With Chemotherapy Significantly Improves Survival Of Gastric Cancer Patients!
